Klotho Neurosciences Inc.

NASDAQ: KLTO · Real-Time Price · USD
0.75
0.07 (10.29%)
At close: Aug 22, 2025, 3:59 PM
0.74
-1.83%
After-hours: Aug 22, 2025, 07:45 PM EDT

Klotho Neurosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Net Income
-4.09M -2.23M -2.07M -2.96M -451.64K -672.04K -126.47K -144.11K -153.55K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
390.19K 495.5K 659.21K 1.95M n/a 287.25K -100K 100K n/a
Other Working Capital
-403.7K -467.75K 516.31K -162.5K -20.24K 53.84K 91.93K 59.48K 64.02K
Other Non-Cash Items
2.19M 649.62K 155.04K -41.02K -435.55K n/a n/a n/a -378.35K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a -45.62K
Change in Working Capital
-457.62K -464.89K 308.86K -25.36K -20.24K 362.82K 26.96K 62.13K 64.02K
Operating Cash Flow
-1.97M -1.55M -944.15K -1.07M -907.42K -21.98K -199.51K 18.02K -513.5K
Capital Expenditures
n/a n/a n/a n/a 3.00 -123.5K n/a -56.33K -5
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a 70K n/a n/a n/a -360K
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a 53.5K n/a 100.18K n/a 63.69M
Investing Cash Flow
n/a n/a n/a n/a n/a -123.5K 100.18K -56.33K 63.33M
Debt Repayment
-2.66M 2.08M 1.08M 150K 822K 50K 114K 45K 360K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
94.47K -19.13K -240K 8.52K 723.42K -50K -114K n/a n/a
Financial Cash Flow
9.83M 2.06M 957K 278.52K 1.72M 175K 100K 45K -62.81M
Net Cash Flow
7.87M 502.13K 12.85K -794.44K 813K 29.53K 667.00 -38.3K n/a
Free Cash Flow
-1.97M -1.55M -944.15K -1.07M -424.86K -145.47K -199.51K -38.3K -513.5K